Skip to main content Back to Top
Advertisement

9/9/2019

Thrombin Topical Solution (Bovine)

Products Affected - Description

    • Thrombin JMI, Pfizer, 20,000 unit, pump spray kit, 1 count, NDC 60793-0217-21
    • Thrombin JMI, Pfizer, 20,000 unit, syringe spray kit, 1 count, NDC 60793-0217-22
    • Thrombin JMI, Pfizer, 20,000 unit, vial, 1 count, NDC 60793-0217-20
    • Thrombin JMI, Pfizer, 5,000 unit, syringe spray kit, 1 count, NDC 60793-0705-05
    • Thrombin JMI, Pfizer, 5,000 unit, Epistaxis kit, 1 count, NDC 60793-0205-05
    • Thrombin JMI, Pfizer, 5,000 unit, vial, 1 count, NDC 60793-0215-05

Reason for the Shortage

    • Pfizer has Thrombin-JMI on shortage due to manufacturing delays.
    • Recombinant thrombin is not affected by this shortage.

Available Products

    • There is insufficient supply for usual ordering

Estimated Resupply Dates

    • Pfizer has Thrombin-JMI 5,000 unit vials and 5,000 unit syringe spray kits available in limited supply. The 20,000 unit pump spray kits are on back order and the company estimates a release date of September 2019. The 20,000 unit vials are on back order and the company estimates a release date of September 2019. The 20,000 unit syringe spray kits are on back order and the company estimates a release date of September 2019.The 5,000 unit epistaxis kits are on back order and the company estimates a release date of December 2019.

Updated

Updated September 9, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. Created October 2, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins